210 related articles for article (PubMed ID: 5561279)
1. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
Ginko T; Adamczyk R; Dyaczyńska A
Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
[No Abstract] [Full Text] [Related]
2. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
[No Abstract] [Full Text] [Related]
3. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
[No Abstract] [Full Text] [Related]
4. [Effect of cardilan on blood flow disorders in the extremities].
Zapalski S; Ciszewski A
Pol Tyg Lek; 1970 Aug; 25(32):1218-20. PubMed ID: 5472553
[No Abstract] [Full Text] [Related]
5. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
Toth L
Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
[No Abstract] [Full Text] [Related]
6. [Complamine in obliterating peripheral circulatory disorders].
Kusztos D; Bereczky M; Fono J
Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
[No Abstract] [Full Text] [Related]
7. [Application of bencyclane in arterial insufficiency of the lower limbs].
Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
[No Abstract] [Full Text] [Related]
8. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
9. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
Baldoni E
G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
[No Abstract] [Full Text] [Related]
10. The action of tetranicotinoylfructose in peripheral vascular disease.
Andrews G; Judge TG; Walkey F
Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
[No Abstract] [Full Text] [Related]
11. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
[No Abstract] [Full Text] [Related]
12. [Experience with Complamin in peripheral circulation disorders].
Wittenburg H
Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
[No Abstract] [Full Text] [Related]
13. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative].
Kienholz E
Med Klin; 1965 Aug; 60(33):1321-4. PubMed ID: 5843335
[No Abstract] [Full Text] [Related]
14. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
15. [Clinical assessment of Cardilan].
Markiewicz M; Korolko A
Pol Tyg Lek; 1970 Nov; 25(47):1816-7. PubMed ID: 5484526
[No Abstract] [Full Text] [Related]
16. Tetranicotinoylfructose in disorders of digital blood flow.
Holti G; Newell DJ; Poole HG
Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
[No Abstract] [Full Text] [Related]
17. [Drug therapy of arterial circulatory disorders with Lioftal].
Greif S
Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
[No Abstract] [Full Text] [Related]
18. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
De Gregorio G; Scaffidi L; Arcoraci A
Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
[No Abstract] [Full Text] [Related]
19. [The influence of nicotinic acid on circulatory disorders of the lower extremities].
Kirsch J; Kirsch J
Landarzt; 1964 Dec; 40(35):1527-30. PubMed ID: 5826399
[No Abstract] [Full Text] [Related]
20. [Contribution to the therapy of blood circulation disorders with tetranicotinoyl-fructofuranose (Nicofuranose)].
Pankiewicz F
Ther Umsch; 1965 Oct; 22(10):494-7. PubMed ID: 5882062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
